Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$501.55M
Total Bought:
$201.48M
Total Sold:
$78.18M
Net Transaction:
+$123.30M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Immunogen Inc01,404,608+1,404,608$0$41.65M8.30%+$41.65M
Cerevel Therapeutics Hldng I685,061750,000+64,939$14.95M$31.80M6.34%+$16.85M
Cymabay Therapeutics Inc1,129,3761,090,441-38,935$16.84M$25.76M5.14%+$8.92M
Madrigal Pharmaceuticals, Inc.(MDGL)85,000100,000+15,000$12.41M$23.14M4.61%+$10.72M
Xenon Pharmaceuticals Inc.(XENE)300,438460,000+159,562$10.26M$21.19M4.22%+$10.92M
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$16.41M$20.58M4.10%+$4.17M
Teva Pharmaceutical Industries LimitedADS(TEVA)2,000,0001,900,000-100,000$20.40M$19.84M3.95%-$564.0K
Arcellx Inc
COMMON STOCK
400,000340,000-60,000$14.35M$18.87M3.76%+$4.52M
LianMedicalADS(LIANY)672,3573,779,694+3,107,337$1.00M$16.90M3.37%+$15.89M
Crinetics Pharmaceuticals In450,000447,095-2,905$13.38M$15.91M3.17%+$2.52M
Celldex Therapeutics, Inc.(CLDX)150,000400,000+250,000$4.13M$15.86M3.16%+$11.74M
Apogee Therapeutics Inc1,045,110537,093-508,017$22.26M$15.01M2.99%-$7.25M
Immunovant, Inc.(IMVT)300,000345,000+45,000$11.52M$14.53M2.90%+$3.02M
Cytokinetics, Incorporated(CYTK)230,366160,000-70,366$6.79M$13.36M2.66%+$6.57M
Nuvalent Inc50,000175,000+125,000$2.30M$12.88M2.57%+$10.58M
Astria Therapeutics Inc1,000,3001,466,465+466,165$7.46M$11.26M2.25%+$3.80M
Verona Pharma PlcADS368,329563,824+195,495$6.00M$11.21M2.23%+$5.21M
Spyre Therapeutics, Inc.(SYRE)242,297517,554+275,257$2.97M$11.14M2.22%+$8.17M
Autolus Therapeutics plcADS(AUTL)1,992,4661,550,408-442,058$4.64M$9.98M1.99%+$5.34M
Alkermes plcSHS(ALKS)100,000356,384+256,384$2.80M$9.89M1.97%+$7.09M
Inozyme Pharma Inc1,379,8521,885,802+505,950$5.80M$8.03M1.60%+$2.24M
Nurix Therapeutics, Inc.(NRIX)250,000690,112+440,112$1.97M$7.12M1.42%+$5.16M
Centessa Pharmaceuticals PlcADS1,018,091795,729-222,362$6.59M$6.33M1.26%-$253.0K
Establishment Labs Holdings Inc.(ESTA)239,108228,277-10,831$11.73M$5.91M1.18%-$5.82M
Mirati Therapeutics Inc60,426100,049+39,623$2.63M$5.88M1.17%+$3.25M
Roivant Sciences Ltd.SHS(ROIV)150,000500,000+350,000$1.75M$5.62M1.12%+$3.86M
Viking Therapeutics, Inc.(VKTX)300,000300,0000$3.32M$5.58M1.11%+$2.26M
Savara Inc.(SVRA)1,150,0001,150,0000$4.35M$5.41M1.08%+$1.06M
COMPASS Pathways plcADS(CMPS)0550,000+550,000$0$4.81M0.96%+$4.81M
Apellis Pharmaceuticals Inc
COM
40,00075,000+35,000$1.52M$4.49M0.90%+$2.97M
MoonLake ImmunotherapeuticsCL A(MLTX)50,00070,988+20,988$2.85M$4.29M0.85%+$1.44M
Dynavax Technologies Corp200,000300,000+100,000$2.95M$4.19M0.84%+$1.24M
AstraZeneca PLCADR(AZN)60,00060,0000$4.06M$4.04M0.81%-$22.2K
Axsome Therapeutics, Inc.(AXSM)050,000+50,000$0$3.98M0.79%+$3.98M
Springworks Therapeutics Inc41,581100,000+58,419$961.4K$3.65M0.73%+$2.69M
Omeros CorpNOTE 5 250 2 1000$0$3.60M0.72%+$3.60M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$0$3.40M0.68%+$3.40M
Relay Therapeutics, Inc.(RLAY)0300,000+300,000$0$3.30M0.66%+$3.30M
BridgeBio Pharma, Inc.(BBIO)30,00080,000+50,000$791.1K$3.23M0.64%+$2.44M
Krystal Biotech, Inc.(KRYS)57,50025,000-32,500$6.67M$3.10M0.62%-$3.57M
Cullinan Therapeutics, Inc.(CGEM)0300,000+300,000$0$3.06M0.61%+$3.06M
Tango Therapeutics, Inc.(TNGX)350,000300,274-49,726$3.94M$2.97M0.59%-$968.3K
argenx SEADR(ARGX)07,500+7,500$0$2.85M0.57%+$2.85M
Kura Oncology, Inc.(KURA)856,535191,535-665,000$7.81M$2.75M0.55%-$5.06M
EyePoint, Inc.(EYPT)0109,900+109,900$0$2.54M0.51%+$2.54M
Ascendis Pharma A/SADR(ASND)46,40020,000-26,400$4.34M$2.52M0.50%-$1.83M
Mersana Therapeutics Inc2,850,0001,000,000-1,850,000$3.62M$2.32M0.46%-$1.30M
Immatics N.V.SHS(IMTX)200,000200,0000$2.32M$2.11M0.42%-$210.0K
Penumbra, Inc.(PEN)07,500+7,500$0$1.89M0.38%+$1.89M
Tourmaline Bio Inc068,081+68,081$0$1.78M0.36%+$1.78M
ADC Therapeutics SASHS(ADCT)1,100,0001,013,540-86,460$986.7K$1.68M0.34%+$695.8K
Vaxcyte, Inc.(PCVX)25,00025,0000$1.27M$1.57M0.31%+$295.5K
Kalvista Pharmaceuticals Inc278,292125,969-152,323$2.68M$1.54M0.31%-$1.14M
Mirum Pharmaceuticals, Inc.(MIRM)30,00050,000+20,000$948.0K$1.48M0.29%+$528.0K
Newamsterdam Pharma Company
ORDINARY SHARES
125,000125,0000$1.16M$1.40M0.28%+$240.0K
Neurocrine Biosciences, Inc.(NBIX)010,000+10,000$0$1.32M0.26%+$1.32M
Inari Med Inc020,000+20,000$0$1.30M0.26%+$1.30M
Allogene Therapeutics Inc0400,000+400,000$0$1.28M0.26%+$1.28M
Morphic Hldg Inc270,00042,670-227,330$6.19M$1.23M0.25%-$4.95M
Viridian Therapeutics, Inc.(VRDN)050,000+50,000$0$1.09M0.22%+$1.09M
Biohaven Ltd.(BHVN)30,15620,866-9,290$784.4K$893.1K0.18%+$108.7K
Puma Biotechnology, Inc.(PBYI)202,349202,3490$532.2K$876.2K0.17%+$344.0K
Fulcrum Therapeutics, Inc.(FULC)0125,000+125,000$0$843.8K0.17%+$843.8K
Avrobio Inc500,000500,0000$770.0K$680.0K0.14%-$90.0K
Immatics N.VW EXP 07 01 202187,204187,2040$662.7K$546.6K0.11%-$116.1K
Newamsterdam Pharma CompanyW EXP 11 22 202
*W EXP 99/99/999
137,000137,0000$260.3K$428.8K0.09%+$168.5K
Terns Pharmaceuticals Inc325,00066,000-259,000$1.63M$428.3K0.09%-$1.21M
Nuvation Bio Inc.CL A(NUVB)250,000250,0000$335.0K$377.5K0.08%+$42.5K
Context Therapeutics Inc.(CNTX)328,817328,8170$496.5K$371.6K0.07%-$125.0K
InflaRx N.V.(IFRX)325,097200,097-125,000$968.8K$326.2K0.07%-$642.6K
Promis Neurosciences Inc265,958265,9580$526.7K$305.9K0.06%-$220.8K
Aravive Inc346,511346,5110$45.7K$42.9K0.01%-$2.9K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)75,00075,0000$7.5K$36.8K0.01%+$29.3K
ALDEYRA THERAPEUTICS INCCOM(ALDX)44,3480-44,348$296.2K$0—-$296.2K
BIOATLA INCCOM(BCAB)180,0000-180,000$306.0K$0—-$306.0K
INSPIRE MED SYS INCCOM(INSP)6,2930-6,293$1.25M$0—-$1.25M
INSULET CORPCOM(PODD)5,0000-5,000$797.5K$0—-$797.5K
LANTHEUS HLDGS INCCOM(LNTH)30,0000-30,000$2.08M$0—-$2.08M
MILESTONE PHARMACEUTICALS INCOM(MIST)335,0680-335,068$1.04M$0—-$1.04M
NLS PHARMACEUTICS LTDSHS200,4550-200,455$140.3K$0—-$140.3K
PROTHENA CORP PLCSHS
SHS
79,2140-79,214$3.82M$0—-$3.82M
SEAGEN INCCOM10,0000-10,000$2.12M$0—-$2.12M
TALARIS THERAPEUTICS INCCOM400,0000-400,000$1.12M$0—-$1.12M
THESEUS PHARMACEUTICALS INCCOM400,7260-400,726$1.08M$0—-$1.08M
TRAVERE THERAPEUTICS INCCOM(TVTX)100,0000-100,000$894.0K$0—-$894.0K
Page 1 of 1
Affinity Asset Advisors, LLC — 13F Holdings — Q4 2023 | TickerTrail